GROUP ONE TRADING, L.P. - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,312,863
-33.0%
73,140
-24.2%
0.00%
-33.3%
Q2 2023$1,959,224
+1180.5%
96,466
+1553.8%
0.01%
Q3 2022$153,000
-67.2%
5,833
-68.4%
0.00%
-100.0%
Q2 2022$467,000
+5737.5%
18,435
+7985.5%
0.00%
Q3 2021$8,000
-74.2%
228
-79.4%
0.00%
Q1 2021$31,000
+342.9%
1,108
+321.3%
0.00%
Q4 2020$7,0002630.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders